iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
1.470
+0.230 (18.55%)
At close: Aug 1, 2025, 4:00 PM
1.500
+0.030 (2.04%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Chimerix Market Cap
iSpecimen has a market cap or net worth of $5.85 million as of August 1, 2025. Its market cap has increased by 46.45% in one year.
Market Cap
5.85M
Enterprise Value
5.37M
1-Year Change
46.45%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on June 17, 2021, iSpecimen's market cap has decreased from $50.15M to $5.85M, a decrease of -88.33%. That is a compound annual growth rate of -40.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 4.93M | 93.07% |
| Dec 31, 2024 | 2.56M | -43.75% |
| Dec 29, 2023 | 4.54M | -62.95% |
| Dec 30, 2022 | 12.26M | -81.98% |
| Dec 31, 2021 | 68.07M | 35.75% |
| Jun 17, 2021 | 50.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.55B |
| Novo Nordisk | 213.92B |